Since the early 1990s, biobanking has been evolving as a key resource, increasing the availability and use of biological material such as DNA, RNA, tissues and cells for biomedical research.
As a result of automation in the pharmaceutical industry, large compound libraries for future analysis and screening for potential drug candidates are routinely created. Alongside an increase in chemical compound samples, the number of biological sam